GeneMatrix (4195) Announces Results of Price Stabilization Operation Following Innovation Board Listing
GeneMatrix (4195) has announced the results of its price stabilization operations for the first five business days following its Innovation Board listing. Taichung Bank Securities purchased a total of 130,000 shares at an underwriting price of NT$22.06 per share.
📋 Article Processing Timeline
- 📰 Published: May 16, 2026 at 12:57
- 🔍 Collected: May 16, 2026 at 12:57 (0 min after Published)
- 🤖 AI Analyzed: May 16, 2026 at 13:49 (51 min after Collected)
Reporting Date: May 16, 2026
Announcement Date: May 15, 2026
Announcement Time: 14:36:42
Company Code: 4195
Company Name: GeneMatrix
Subject: Results of Price Stabilization Operations for the First Five Business Days Following the Company's Innovation Board Listing
Applicable Clause: Article 51
Event Date: May 15, 2026
Explanation:
1. Event Date: May 15, 2026
2. Company Name: GeneMatrix Biotech Co., Ltd.
3. Relationship with the Company: The Company
4. Mutual Shareholding Ratio: Not Applicable
5. Reason for Event: In accordance with the "Procedures for Underwriters Handling Initial Listing (OTC) Cases" of the Taipei Exchange, the company is announcing the results of its price stabilization operations for the first five business days following its listing.
6. Response Measures: None
7. Other Required Matters:
(1) Lead Underwriter: Taichung Bank Securities Co., Ltd.
(2) Security Name, Code: GeneMatrix (Stock Code: 4195)
(3) Actual Over-allotment Quantity: 130,000 shares
(4) Underwriting Price: NT$22.06 per share
(5) Proceeds from Over-allotment: NT$2,867,800
(6) Stabilization Period: May 11, 2026 - May 15, 2026
(7) Cumulative Quantity Purchased in the "Price Stabilization Account" by the Lead Underwriter: 130,000 shares
Announcement Date: May 15, 2026
Announcement Time: 14:36:42
Company Code: 4195
Company Name: GeneMatrix
Subject: Results of Price Stabilization Operations for the First Five Business Days Following the Company's Innovation Board Listing
Applicable Clause: Article 51
Event Date: May 15, 2026
Explanation:
1. Event Date: May 15, 2026
2. Company Name: GeneMatrix Biotech Co., Ltd.
3. Relationship with the Company: The Company
4. Mutual Shareholding Ratio: Not Applicable
5. Reason for Event: In accordance with the "Procedures for Underwriters Handling Initial Listing (OTC) Cases" of the Taipei Exchange, the company is announcing the results of its price stabilization operations for the first five business days following its listing.
6. Response Measures: None
7. Other Required Matters:
(1) Lead Underwriter: Taichung Bank Securities Co., Ltd.
(2) Security Name, Code: GeneMatrix (Stock Code: 4195)
(3) Actual Over-allotment Quantity: 130,000 shares
(4) Underwriting Price: NT$22.06 per share
(5) Proceeds from Over-allotment: NT$2,867,800
(6) Stabilization Period: May 11, 2026 - May 15, 2026
(7) Cumulative Quantity Purchased in the "Price Stabilization Account" by the Lead Underwriter: 130,000 shares